Q BioMed Inc. (QBIO)

Q BioMed Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb 28, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018
Cash & Equivalents	0.02	0.05	0.34	0.18	0.17	2.68
Cash & Short-Term Investments	0.02	0.05	0.34	0.18	0.17	2.68
Cash Growth	-83.11%	-85.47%	94.20%	2.61%	-93.57%	225.47%
Receivables	-	0.01	0.08	-	-	-
Inventory	-	-	0.02	-	-	-
Prepaid Expenses	0.01	0.01	0.01	0.05	0.02	0.01
Total Current Assets	0.03	0.07	0.46	0.22	0.19	2.7
Long-Term Investments	3.14	3.14	-	-	-	-
Other Intangible Assets	0.29	0.3	0.35	0.4	0.45	0.5
Total Assets	3.46	3.52	0.81	0.62	0.64	3.2
Accounts Payable	2.25	2.13	1.35	0.72	0.65	0.17
Accrued Expenses	3.48	1.8	1.1	0.89	1.34	0.26
Short-Term Debt	4.08	4.11	3.05	0.09	0.5	-
Current Portion of Long-Term Debt	-	-	-	0	2.74	-
Other Current Liabilities	0.09	0.09	-	-	-	-
Total Current Liabilities	9.91	8.13	5.49	1.7	5.24	0.43
Long-Term Debt	-	-	-	-	0.45	2.87
Other Long-Term Liabilities	-	-0	-	-	-	-
Total Liabilities	9.91	8.13	5.49	1.7	5.69	3.3
Common Stock	0.13	0.08	0.03	0.02	0.02	0.01
Additional Paid-In Capital	56.55	56.31	53.34	47.66	37.33	31.99
Retained Earnings	-68.32	-66.1	-64.13	-55.89	-42.39	-32.11
Total Common Equity	-11.63	-9.7	-10.76	-8.21	-5.05	-0.11
Shareholders' Equity	-6.44	-4.62	-4.69	-1.08	-5.05	-0.11
Total Liabilities & Equity	3.46	3.52	0.81	0.62	0.64	3.2
Total Debt	4.08	4.11	3.05	0.09	3.69	2.87
Net Cash (Debt)	-4.06	-4.06	-2.71	0.08	-3.52	-0.19
Net Cash Per Share	-0.06	-0.09	-0.10	0.00	-0.23	-0.01
Filing Date Shares Outstanding	145.09	144.09	30.6	25.86	20.84	14.47
Total Common Shares Outstanding	133.03	84.33	28.65	23.82	19.71	14.29
Working Capital	-9.87	-8.06	-5.04	-1.48	-5.05	2.27
Book Value Per Share	-0.09	-0.12	-0.38	-0.34	-0.26	-0.01
Tangible Book Value	-11.92	-10	-11.11	-8.61	-5.5	-0.61
Tangible Book Value Per Share	-0.09	-0.12	-0.39	-0.36	-0.28	-0.04

Source: S&P Capital IQ. Standard template. Financial Sources.